[Compbio-allhands] Fwd: Advertising a Joint OpenFF-XtalPi Distinguished Postdoctoral Fellowship

— Matt Begin forwarded message: From: Michael R Shirts <Michael.Shirts@Colorado.EDU<mailto:Michael.Shirts@Colorado.EDU>> Subject: Advertising a Joint OpenFF-XtalPi Distinguished Postdoctoral Fellowship Date: May 3, 2018 at 11:36:31 AM PDT Cc: David Mobley <dmobley@uci.edu<mailto:dmobley@uci.edu>>, Lee-Ping Wang <leeping@ucdavis.edu<mailto:leeping@ucdavis.edu>>, "John Chodera" <john.chodera@choderalab.org<mailto:john.chodera@choderalab.org>>, "Gilson, Michael" <mgilson@ucsd.edu<mailto:mgilson@ucsd.edu>> Hello, colleagues- The Open Force Field Consortium (OpenFF, openforcefield.org<http://openforcefield.org>) and XtalPi, Inc. (xtalpi.com<http://xtalpi.com>) are seeking a postdoctoral fellow to perform cutting-edge research in a unique academic-industrial joint effort. The postdoctoral fellow will work with OpenFF and XtalPi to improve the accuracy of molecular mechanics force fields for predicting crystal structures and binding free energies. Please pass this opportunity on to any of your recent students or postdocs that might be interested. See the full ad here: http://www.ccl.net/cca/jobs/joblist/mess0044564.shtml This particular postdoctoral position has some interesting advantages such as 1) the opportunity to transition into an industrial position doing computational chemistry right afterwards, 2) the chance to work in a highly collaborative team setting, and 3) flexibility to be located at any of the participating academic institutions. OpenFF is an academic collaboration (based at UC Irvine / UC Davis / UC San Diego / Univ. Colorado Boulder / Sloan Kettering Institute in New York) that seeks to develop next-generation molecular mechanics force fields and associated parameterization software and data infrastructure. XtalPi is a pharmaceutical technology company founded in 2014 that is introducing revolutionary advances in drug research and development, and has established strategic partnerships with several major pharmaceutical companies and recently completed a Series B funding round with Sequoia, Tencent, and Google. Best, ~~~~~~~~~~~~~~~~ Michael Shirts Associate Professor michael.shirts@colorado.edu<mailto:michael.shirts@colorado.edu> http://www.colorado.edu/lab/shirtsgroup/ Phone: (303) 735-7860 Office: JSCBB C123 Department of Chemical and Biological Engineering University of Colorado Boulder
participants (1)
-
Jacobson, Matt